Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
Nicoleta Mirela Blebea(Ovidius University), Cornel Chiriță(Carol Davila University of Medicine and Pharmacy), Alina Mihaela Stăniguț(Ovidius University), Gabriel Hancu(Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș), Ciprian Pușcașu(Carol Davila University of Medicine and Pharmacy)
Cited by 2
Related Papers
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
|International Journal of Molecular Sciences|2024|72
Chitosan-Based Gel Development: Extraction, Gelation Mechanisms, and Biomedical Applications
|Gels|2025|40
Autophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
|International Journal of Molecular Sciences|2025|18
Very Fast RP–UHPLC–PDA Method for Identification and Quantification of the Cannabinoids from Hemp Oil
|Applied Sciences|2021|14
Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics
|Drugs and Drug Candidates|2024|13